Search results
Results from the WOW.Com Content Network
Cholesterol drugs Zetia and Vytorin together accounted for 10% of Merck's pharma sales last year. But while Zetia managed to recover from a sales plunge, the duo's end is still in sight. Big fall
The bad news: Its stock was down more than 10% in early trading, largely because of weaker-than-expected 2025 guidance. Merck reported $64.2 billion in sales for 2024, a 7% increase compared with ...
Merck gained Food and Drug Administration approval for its powerful new cholesterol drug Liptruzet, a combination of two already-approved drugs, Pfizer's Lipitor and Merck's Zetia. Merck already ...
It is a combination of ezetimibe (known as Zetia in the United States) and the statin drug simvastatin (known as Zocor in the US). Ezetimibe reduces blood cholesterol by acting at the brush border of the small intestine and inhibiting the absorption of cholesterol, leading to a decrease in the delivery of intestinal cholesterol to the liver.
Ezetimibe, sold under the brand name Zetia among others, is a medication used to treat high blood cholesterol and certain other lipid abnormalities. [ 3 ] [ 4 ] Generally it is used together with dietary changes and a statin . [ 5 ]
Merck & Co. traces its origins to its former German parent company Merck Group, which was established by the Merck family in 1668 when Friedrich Jacob Merck purchased a drug store in Darmstadt. [ 27 ] [ 28 ] In 1827, Merck Group evolved from a pharmacy to a drug manufacturer company with the commercial manufacture of morphine . [ 29 ]
The decision comes a little over a week after President Donald J. Trump singled out rival Pfizer over its price increases. The list price of Zepatier had been $54,600 for a course of treatment ...
But this time it's Pfizer (NYS: PFE) and Merck (NYS: Usually, it's a branded drugmaker fighting off a generics challenge from a copycat drugmaker. Pfizer Sues Merck to Block Lipitor/Zetia Combo Pill